当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2014年
22期
4-6
,共3页
压力超负荷%大鼠%依那普利%心肌纤维化%微小RNA-214
壓力超負荷%大鼠%依那普利%心肌纖維化%微小RNA-214
압력초부하%대서%의나보리%심기섬유화%미소RNA-214
Pressure overload%Rat%Enalapril%Myocardial fibrosis%microRNA-214
目的:探讨压力超负荷导致心肌纤维化过程中microRNA-214的表达变化,以及依那普利对心肌纤维化的影响。方法80只雄性SD大鼠随机分为压力超负荷组(Model,n=40),假手术组(Sham,n=40)。其中各组再随机分为两个亚组:依那普利治疗组(n=20)与无依那普利治疗组(n=20)。行腹主动脉缩窄术建立心脏压力超负荷大鼠模型。4周后,酶联免疫分析法测定各组大鼠血清中的PICP、ICTP、MMP-2、TIMP-2等心肌纤维化指标,荧光实时定量PCR技术检测的microRNA-214表达变化。结果压力超负荷组大鼠的PICP为(161.3±16.3)ng/L、ICTP为(3.06±0.5)、PICP/ICTP 比值为(51.1±7.3)、MMP-2为(2638.2±289.6)pg/mL、TIMP-2为(4396±365.9)ng/mL,上述指标与假手术相比,均有所增高,差异具有统计学意义(P均<0.05);模型组MMP-2/TIMP-2比值为(0.6±0.4),显著低于假手术组(P<0.05),依那普利处理亚组的大鼠PICP为(114.1±19.6)ng/L、ICTP为(2.5±0.7)ng/L、PICP/ICTP比值为(45.1±16.3)、MMP-2为(806.8±301.6)pg/mL、TIMP-2为(2052.6±322.3),均低于单纯压力超负荷组,异具有统计学意义(P均<0.05)。依那普利处理亚组MMP-2/TIMP-2比值为(0.88±0.3),显著高于单纯压力超负荷组,差异具有统计学意义(P均<0.05)。同时压力超负荷处理会导致microRNA-214的表达相对于假手术组增高(2.1±0.3)倍,依那普利处理可以缓解压力超负荷引起的microRNA-21过表达,但仍为假手术组的(1.5±0.2)倍。结论依那普利可以缓解压力超负荷造成的心肌纤维化,microRNA-214与此过程有关,可作为心肌纤维化的治疗靶点或标志物。
目的:探討壓力超負荷導緻心肌纖維化過程中microRNA-214的錶達變化,以及依那普利對心肌纖維化的影響。方法80隻雄性SD大鼠隨機分為壓力超負荷組(Model,n=40),假手術組(Sham,n=40)。其中各組再隨機分為兩箇亞組:依那普利治療組(n=20)與無依那普利治療組(n=20)。行腹主動脈縮窄術建立心髒壓力超負荷大鼠模型。4週後,酶聯免疫分析法測定各組大鼠血清中的PICP、ICTP、MMP-2、TIMP-2等心肌纖維化指標,熒光實時定量PCR技術檢測的microRNA-214錶達變化。結果壓力超負荷組大鼠的PICP為(161.3±16.3)ng/L、ICTP為(3.06±0.5)、PICP/ICTP 比值為(51.1±7.3)、MMP-2為(2638.2±289.6)pg/mL、TIMP-2為(4396±365.9)ng/mL,上述指標與假手術相比,均有所增高,差異具有統計學意義(P均<0.05);模型組MMP-2/TIMP-2比值為(0.6±0.4),顯著低于假手術組(P<0.05),依那普利處理亞組的大鼠PICP為(114.1±19.6)ng/L、ICTP為(2.5±0.7)ng/L、PICP/ICTP比值為(45.1±16.3)、MMP-2為(806.8±301.6)pg/mL、TIMP-2為(2052.6±322.3),均低于單純壓力超負荷組,異具有統計學意義(P均<0.05)。依那普利處理亞組MMP-2/TIMP-2比值為(0.88±0.3),顯著高于單純壓力超負荷組,差異具有統計學意義(P均<0.05)。同時壓力超負荷處理會導緻microRNA-214的錶達相對于假手術組增高(2.1±0.3)倍,依那普利處理可以緩解壓力超負荷引起的microRNA-21過錶達,但仍為假手術組的(1.5±0.2)倍。結論依那普利可以緩解壓力超負荷造成的心肌纖維化,microRNA-214與此過程有關,可作為心肌纖維化的治療靶點或標誌物。
목적:탐토압력초부하도치심기섬유화과정중microRNA-214적표체변화,이급의나보리대심기섬유화적영향。방법80지웅성SD대서수궤분위압력초부하조(Model,n=40),가수술조(Sham,n=40)。기중각조재수궤분위량개아조:의나보리치료조(n=20)여무의나보리치료조(n=20)。행복주동맥축착술건립심장압력초부하대서모형。4주후,매련면역분석법측정각조대서혈청중적PICP、ICTP、MMP-2、TIMP-2등심기섬유화지표,형광실시정량PCR기술검측적microRNA-214표체변화。결과압력초부하조대서적PICP위(161.3±16.3)ng/L、ICTP위(3.06±0.5)、PICP/ICTP 비치위(51.1±7.3)、MMP-2위(2638.2±289.6)pg/mL、TIMP-2위(4396±365.9)ng/mL,상술지표여가수술상비,균유소증고,차이구유통계학의의(P균<0.05);모형조MMP-2/TIMP-2비치위(0.6±0.4),현저저우가수술조(P<0.05),의나보리처리아조적대서PICP위(114.1±19.6)ng/L、ICTP위(2.5±0.7)ng/L、PICP/ICTP비치위(45.1±16.3)、MMP-2위(806.8±301.6)pg/mL、TIMP-2위(2052.6±322.3),균저우단순압력초부하조,이구유통계학의의(P균<0.05)。의나보리처리아조MMP-2/TIMP-2비치위(0.88±0.3),현저고우단순압력초부하조,차이구유통계학의의(P균<0.05)。동시압력초부하처리회도치microRNA-214적표체상대우가수술조증고(2.1±0.3)배,의나보리처리가이완해압력초부하인기적microRNA-21과표체,단잉위가수술조적(1.5±0.2)배。결론의나보리가이완해압력초부하조성적심기섬유화,microRNA-214여차과정유관,가작위심기섬유화적치료파점혹표지물。
Objective To investigate the expression of microRNA-214 in the myocardial fibrosis induced by pressure-overloaded treatment and the effect of enalapril in this process. Methods 80 male Spargue Dawley rats randomly was divided two groups:sham-operation group (n=40) and pressure-overloaded group (n=40) ,each group was divided two subgroups:enalapril treatment subgroup (n=20) and without enalapril treatment subgroup (n=20). Using ELISA kits to detect the level of PICP, ICTP, MMP-2 and TIMP-2 in serum, furthermore qrt-PCR was used to analyzed the expression of microRNA-214. Results Compared with the sham group pressure-overloaded treatment can increase the level of PICP, ICTP, PICP/ICTP ratio, MMP-2 and TIMP-2 significantly[(161.3±16.3) ng/L, (3.06±0.5), (51.1±7.3), (2638.2±289.6 )pg/mL, (4396±365.9)ng/mL, P<0.05], after enalapril treatment the level of PICP, ICTP, PICP/ICTP ratio, MMP-2 and TIMP-2 were decreased[(2.5±0.7)ng/L, (45.1±16.3), (806.8±301.6) pg/mL, (2052.6±322.3),P<0.05]. MPP-2/TIMP-2 ratio was (0.6±0.4) that is the lowest in pressure-overloaded group , After enalapril treatmen, MPP-2/TIMP-2 ratio was elevated to (0.88±0.3). Meanwhile pressure-overloaded treatment can induce microRNA-214 overexpression[(2.1±0.3) fold relative to Sham group] and enalapril can decreased the expression of microRNA-214[(1.5±0.2) fold relative to Sham group]. Conclusion Enalapril can relieve the myocardial fibrosis caused by pressure-overloaded treatment and microRNA-214, which may be a target or indicator for therapy of myocardial fibrosis, was involved in this process.